FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
AvenCell Therapeutics, Inc.
Incyte Corporation
Allogene Therapeutics
Ossium Health, Inc.
Ossium Health, Inc.
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Center for International Blood and Marrow Transplant Research
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center